|
|
|
|
|
|
|
|
|
|
Previous: ALPHARMA INC, 10-Q, 2000-08-07 |
Next: ALPHARMA INC, 10-Q, EX-4, 2000-08-07 |
<TABLE> <S> <C>
<ARTICLE> 5
<MULTIPLIER> 1000
<S> <C>
<PERIOD-TYPE> 6-MOS
<FISCAL-YEAR-END> DEC-31-2000
<PERIOD-END> JUN-30-2000
<CASH> 22,046
<SECURITIES> 0
<RECEIVABLES> 219,137
<ALLOWANCES> 0
<INVENTORY> 231,614
<CURRENT-ASSETS> 487,362
<PP&E> 502,573
<DEPRECIATION> 181,044
<TOTAL-ASSETS> 1,492,163
<CURRENT-LIABILITIES> 201,440
<BONDS> 370,119
0
0
<COMMON> 7,032
<OTHER-SE> 526,756
<TOTAL-LIABILITY-AND-EQUITY> 1,492,163
<SALES> 407,825
<TOTAL-REVENUES> 407,825
<CGS> 219,453
<TOTAL-COSTS> 219,453
<OTHER-EXPENSES> 131,390
<LOSS-PROVISION> 0
<INTEREST-EXPENSE> 23,913
<INCOME-PRETAX> 29,160
<INCOME-TAX> 10,214
<INCOME-CONTINUING> 18,946
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> 18,946
<EPS-BASIC> .61
<EPS-DILUTED> .59
</TABLE>
|
|